Development of radiolabeled molecular imaging probes for in vivo analysis of biological function

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Molecular imaging is a newly emerging field aimed at advancing our understanding of biology and medicine through the noninvasive in vivo investigation of cellular molecular events involved in normal and pathologic processes. In this field, researchers and/or clinicians are combining modern tools of molecular and cell biology with state of the art technology in order to noninvasively image living subjects. Various imaging modalities such as optics (fluorescence and luminescence), nuclear magnetic resonance imaging, ultrasound, and radiation are being used to visually capture and study molecular and cellular events in living organisms. Among these modalities, nuclear medical molecular imaging uses radionuclides [i.e., positron emission tomography (PET) and single-photon emission computed tomography (SPECT)], and has characteristic properties that allow researchers and/or clinicians to obtain functional images of living subjects with high sensitivity. Translational molecular imaging, a research step between animal experiments and the clinical setting, has been successful when using nuclear medical molecular imaging. This approach leads to better methods for studying biological processes, as well as for diagnosing and managing diseases. In this review, two topics associated with our research on nuclear medical molecular imaging are summarized: (1) the development of a nuclear medical molecular imaging probe that targets cerebral nicotinic acetylcholine receptors (nAChRs), and the translational molecular imaging research conducted using this nAChR imaging probe; and (2) the development of oxygen-dependent degradable nuclear medical molecular imaging probes that target hypoxia-inducible factor-1-active tumor microenvironments.

Original languageEnglish
Pages (from-to)659-668
Number of pages10
JournalYakugaku Zasshi
Volume136
Issue number4
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Molecular Probes
Molecular Imaging
Diagnostic Imaging
Research
Research Personnel
Biological Phenomena
Hypoxia-Inducible Factor 1
Tumor Microenvironment
Nicotinic Receptors
Pathologic Processes
Luminescence
Single-Photon Emission-Computed Tomography
Radioisotopes
Positron-Emission Tomography
Cell Biology
Molecular Biology
Magnetic Resonance Spectroscopy
Fluorescence
Magnetic Resonance Imaging
Medicine

Keywords

  • Hypoxia-inducible factor-1
  • Molecular imaging
  • Nicotinic acetylcholine receptor
  • Positron emission tomography
  • Radioactive probe
  • Single-photon emission computed tomography

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Development of radiolabeled molecular imaging probes for in vivo analysis of biological function. / Ueda, Masashi.

In: Yakugaku Zasshi, Vol. 136, No. 4, 01.04.2016, p. 659-668.

Research output: Contribution to journalArticle

@article{fff97f0076a74c6395fb854b1c17a867,
title = "Development of radiolabeled molecular imaging probes for in vivo analysis of biological function",
abstract = "Molecular imaging is a newly emerging field aimed at advancing our understanding of biology and medicine through the noninvasive in vivo investigation of cellular molecular events involved in normal and pathologic processes. In this field, researchers and/or clinicians are combining modern tools of molecular and cell biology with state of the art technology in order to noninvasively image living subjects. Various imaging modalities such as optics (fluorescence and luminescence), nuclear magnetic resonance imaging, ultrasound, and radiation are being used to visually capture and study molecular and cellular events in living organisms. Among these modalities, nuclear medical molecular imaging uses radionuclides [i.e., positron emission tomography (PET) and single-photon emission computed tomography (SPECT)], and has characteristic properties that allow researchers and/or clinicians to obtain functional images of living subjects with high sensitivity. Translational molecular imaging, a research step between animal experiments and the clinical setting, has been successful when using nuclear medical molecular imaging. This approach leads to better methods for studying biological processes, as well as for diagnosing and managing diseases. In this review, two topics associated with our research on nuclear medical molecular imaging are summarized: (1) the development of a nuclear medical molecular imaging probe that targets cerebral nicotinic acetylcholine receptors (nAChRs), and the translational molecular imaging research conducted using this nAChR imaging probe; and (2) the development of oxygen-dependent degradable nuclear medical molecular imaging probes that target hypoxia-inducible factor-1-active tumor microenvironments.",
keywords = "Hypoxia-inducible factor-1, Molecular imaging, Nicotinic acetylcholine receptor, Positron emission tomography, Radioactive probe, Single-photon emission computed tomography",
author = "Masashi Ueda",
year = "2016",
month = "4",
day = "1",
doi = "10.1248/yakushi.15-00279",
language = "English",
volume = "136",
pages = "659--668",
journal = "Yakugaku Zasshi",
issn = "0031-6903",
publisher = "Pharmaceutical Society of Japan",
number = "4",

}

TY - JOUR

T1 - Development of radiolabeled molecular imaging probes for in vivo analysis of biological function

AU - Ueda, Masashi

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Molecular imaging is a newly emerging field aimed at advancing our understanding of biology and medicine through the noninvasive in vivo investigation of cellular molecular events involved in normal and pathologic processes. In this field, researchers and/or clinicians are combining modern tools of molecular and cell biology with state of the art technology in order to noninvasively image living subjects. Various imaging modalities such as optics (fluorescence and luminescence), nuclear magnetic resonance imaging, ultrasound, and radiation are being used to visually capture and study molecular and cellular events in living organisms. Among these modalities, nuclear medical molecular imaging uses radionuclides [i.e., positron emission tomography (PET) and single-photon emission computed tomography (SPECT)], and has characteristic properties that allow researchers and/or clinicians to obtain functional images of living subjects with high sensitivity. Translational molecular imaging, a research step between animal experiments and the clinical setting, has been successful when using nuclear medical molecular imaging. This approach leads to better methods for studying biological processes, as well as for diagnosing and managing diseases. In this review, two topics associated with our research on nuclear medical molecular imaging are summarized: (1) the development of a nuclear medical molecular imaging probe that targets cerebral nicotinic acetylcholine receptors (nAChRs), and the translational molecular imaging research conducted using this nAChR imaging probe; and (2) the development of oxygen-dependent degradable nuclear medical molecular imaging probes that target hypoxia-inducible factor-1-active tumor microenvironments.

AB - Molecular imaging is a newly emerging field aimed at advancing our understanding of biology and medicine through the noninvasive in vivo investigation of cellular molecular events involved in normal and pathologic processes. In this field, researchers and/or clinicians are combining modern tools of molecular and cell biology with state of the art technology in order to noninvasively image living subjects. Various imaging modalities such as optics (fluorescence and luminescence), nuclear magnetic resonance imaging, ultrasound, and radiation are being used to visually capture and study molecular and cellular events in living organisms. Among these modalities, nuclear medical molecular imaging uses radionuclides [i.e., positron emission tomography (PET) and single-photon emission computed tomography (SPECT)], and has characteristic properties that allow researchers and/or clinicians to obtain functional images of living subjects with high sensitivity. Translational molecular imaging, a research step between animal experiments and the clinical setting, has been successful when using nuclear medical molecular imaging. This approach leads to better methods for studying biological processes, as well as for diagnosing and managing diseases. In this review, two topics associated with our research on nuclear medical molecular imaging are summarized: (1) the development of a nuclear medical molecular imaging probe that targets cerebral nicotinic acetylcholine receptors (nAChRs), and the translational molecular imaging research conducted using this nAChR imaging probe; and (2) the development of oxygen-dependent degradable nuclear medical molecular imaging probes that target hypoxia-inducible factor-1-active tumor microenvironments.

KW - Hypoxia-inducible factor-1

KW - Molecular imaging

KW - Nicotinic acetylcholine receptor

KW - Positron emission tomography

KW - Radioactive probe

KW - Single-photon emission computed tomography

UR - http://www.scopus.com/inward/record.url?scp=84962432291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962432291&partnerID=8YFLogxK

U2 - 10.1248/yakushi.15-00279

DO - 10.1248/yakushi.15-00279

M3 - Article

VL - 136

SP - 659

EP - 668

JO - Yakugaku Zasshi

JF - Yakugaku Zasshi

SN - 0031-6903

IS - 4

ER -